Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT04921943 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Hypertonic Saline for MAC

StatusRecruiting
PhasePhase 4
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated August 15, 2025 (before its estimated December 31, 2025 completion). Its status may not reflect the trial's current state.

Record History

  1. Notable Primary and study completion dates: Jun 30, 2025 to Dec 31, 2025
    • Site details revised at 2 of 3 sites
    v6
  2. Notable Primary completion date: Jun 30, 2023 to Jun 30, 2025
    • Study completion date: Dec 31, 2023 to Jun 30, 2025
    • Site contacts updated at 1 of 3 sites
    v5
  3. Minor Site details revised at 2 of 3 sitesv4
  4. Notable Primary completion date: Jun 30, 2022 to Jun 30, 2023
    • Study completion date: Dec 31, 2022 to Dec 31, 2023
    • Site contacts updated at 1 of 3 sites
    v3
  5. Minor Site details revised at 2 of 3 sitesv2
  6. Minor Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The MAC-HS study is a testing whether hypertonic saline helps improve symptoms and clearance of mycobacteria in patients with M. avium complex lung infections.
Trial Details
NCT Number NCT04921943
Lead Sponsor Oregon Health and Science University
Collaborators: NTM Info & Research, Inc., University Health Network, Toronto, New York University
Conditions
(from sponsor)
Nontuberculous Mycobacterial Lung Disease, Nontuberculous Mycobacterium Infection
Related terms Mycobacterium Infections, Nontuberculous
Enrollment 50 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov